CMS responds to stakeholder concerns over compliance burdens in newly released 2018 proposed MACRA rule.
The implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) may have an unexpected consequence for many oncology practices, according to a study from the American Society of Clinical Oncology.
As the MACRA transition gets underway, it will be crucial for providers to use 2017 to get their IT capabilities up to speed in order to be successful under the new law.
As providers gear up to meet reporting requirements under MACRA’s new Quality Payment Program, HIM stands to play a prominent role in the transition to value-based care.
While the final rule contains many different provisions, this article looks at the advantages and disadvantages of four MACRA options providers can choose to implement in 2017.